Source: Virtual Congress 2021 – Chronic COVID - 19



Rating:

Share or cite this content

Citations should be made in the following way:
O. Sibila Vidal (Barcelona, Spain), N. Albacar (Barcelona, Spain), L. Perea (Barcelona, Spain), T. Garcia (Barcelona, Spain), N. Mendoza (Barcelona, Spain), T. Cruz (Barcelona, Spain), S. Casas (Barcelona, Spain), J. Moisés (Barcelona, Spain), J. Badia (Barcelona, Spain), J. Barberà (Barcelona, Spain), A. Agustí (Barcelona, Spain), J. Sellarés (Barcelona, Spain), R. Faner (Barcelona, Spain), L. Perea Soriano (Barcelona (CT), Spain). Systemic SP-A is increased in COVID-19 patients with abnormal diffusion capacity 6 months after hospital discharge. 85

Member's Comments

No comment yet.

Related content which might interest you: Abnormal pulmonary function in COVID-19 patients at time of hospital discharge Source: Eur Respir J, 55 (6) 2001217; 10.1183/13993003.01217-2020 Year: 2020 Half of COVID-19 ICU-treated patients have impaired lung function four months after discharge Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation Year: 2021 Predicting factors of pulmonary functional sequelae in COVID-19 patients after 4 months from hospital admission Source: Virtual Congress 2021 – Long COVID - 19 Year: 2021 Reduction of the systemic inflammatory response in patients with CAP treated with corticosteroids improves clinical outcome and reduces mortality and ICU admittance Source: Annual Congress 2011 - Pulmonary infections and sepsis Year: 2011 To establish the characteristics which influence patients with an acute exacerbation of COPD to die within 2 weeks of hospital admission compared to those after a 2-week period Source: Eur Respir J 2005; 26: Suppl. 49, 283s Year: 2005 Pulmonary function and tomographic features of COVID-19 survivors 2 months after hospital discharge: a cohort study Source: Virtual Congress 2021 – Long COVID - 19 Year: 2021 An increase in steps per day 6 weeks after pulmonary rehabilitation of COPD patients correlates with an improvement in quality of life Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 Rehospitalization rates for patients with pneumonia who require supplemental oxygen therapy following hospital discharge Source: Annual Congress 2012 - The latest insights in integrated care Year: 2012 The impact of time of mechanical ventilation and hospitalization on functional capacity after discharge in patients with COVID-19 pneumonia Source: Virtual Congress 2021 – Assessing the impact of COVID-19 on lung function Year: 2021 The first twelve months of a nurse led oxygen assessment clinic for COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 512s Year: 2003 Effect on outcome of antibiotic treatment during the 2 weeks before hospital admission for community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Reslizumab reduces severe exacerbations associated with emergency department visit or hospitalization and improves measures of lung function in patients on maintenance oral corticosteroids (OCS) at baseline Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Air-trapping and decreased diffusion capacity in patients with severe asthma Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Pulmonary function and respiratory outcomes at 12-24 months in preterm infants randomized to a rescue course of antenatal steroids Source: Annual Congress 2010 - Ventilating the premature lung: current practice and outcomes Year: 2010 Impact of an in-patient pulmonary rehabilitation programme on functional capacity and length of hospital stay in hospitalised COPD patients Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009 Increase in health status after 12 days treatment with inhaled mannitol in patients with bronchiectasis Source: Eur Respir J 2003; 22: Suppl. 45, 430s Year: 2003 EABPCO-CPHG study: Prognosis factors of death and/or hospital admission in 1,142 patients, at 3 months after their admission to the pneumology department of a French general hospital for COPD acute exacerbation (AE) Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Predictors of benefit persistence after 6 months from a pulmonary rehabilitation programme in moderate-severe COPD patients Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008 A delay in reaching time to clinical stability (tcs) for hospitalized patients with community-acquired pneumonia (CAP) is associated with failure within 30 days after hospital discharge Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Are the benefits of pulmonary rehabilitation sustained after 6 months? Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation Year: 2011